Putative Role Of Fgf 23 In The Development Of Hypophosphatemia And Bone Fructures In An Anemic Patient Treated By Intravenous Saccharated Ferric Oxide
A post-menopausal patient with normal kidney function was referred to our hospital because of severe lumber pain. She had been treated by initially oral, and then by intravenous iron for longer than five years for the treatment of iron deficiency anemia due to recurrent GI bleeding. On admission, mu...
Saved in:
Main Authors: | Risa Ishida (Author), Shohei Nakanishi (Author), Sachie Hisose (Author), Jong Il Kim (Author) |
---|---|
Format: | Book |
Published: |
The Korean Society of Nephrology,
2012-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Retrospective Case Reports of Anemic Pregnant Women Receiving Intravenous Ferric Carboxymaltose: Experience from a Tertiary Hospital in Spain
by: Rafael Aporta Rodriguez, et al.
Published: (2016) -
Safety and Efficacy of Ferric Carboxymaltose in Anemic Pregnant Women: A Retrospective Case Control Study
by: Anouk Pels, et al.
Published: (2015) -
Pharmaceutical stability of colloidal saccharated iron oxide injection in normal saline
by: Daiki Hira, et al.
Published: (2018) -
Incidence of postpartum depression after treatment of postpartum anaemia with intravenous ferric carboxymaltose, intravenous ferric derisomaltose or oral ferrous sulphate: A randomized clinical trial
by: Lea Bombač Tavčar, et al.
Published: (2023) -
Il Fibroblast Growth Factor-23 (FGF-23)
by: D. Rendina, et al.
Published: (2018)